Loading...

Drugs Made In America Acquisition Corp. Units

DMAAUNASDAQ
Financial Services
Financial - Conglomerates
$10.97
$0.39(3.73%)
U.S. Market opens in 13h 59m

Drugs Made In America Acquisition Corp. Units (DMAAU) Stock Competitors & Peer Comparison

See (DMAAU) competitors and their performances in Stock Market.

Peer Comparison Table: Financial - Conglomerates Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
DMAAU$10.97+3.73%257.1MN/AN/AN/A
TPGXL$25.14+0.20%23.8BN/AN/A+4.61%
VOYA-PB$23.85+0.08%7.3B2.84$8.44+2.47%
VOYA$74.45+2.25%7.1B11.84$6.29+2.47%
BIPH$16.50+0.55%6BN/AN/A+7.55%
PACS$35.20+2.55%5.5B28.88$1.22N/A
MSDL$15.36+0.66%1.3B10.98$1.40+12.68%
RILYK$25.23+0.16%787.6MN/AN/AN/A
RILYN$24.29+0.02%758.3MN/AN/AN/A
RILYM$25.11+0.00%753MN/AN/AN/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

DMAAU vs TPGXL Comparison April 2026

DMAAU plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DMAAU stands at 257.1M. In comparison, TPGXL has a market cap of 23.8B. Regarding current trading prices, DMAAU is priced at $10.97, while TPGXL trades at $25.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DMAAU currently has a P/E ratio of N/A, whereas TPGXL's P/E ratio is N/A. In terms of profitability, DMAAU's ROE is +0.02%, compared to TPGXL's ROE of +0.16%. Regarding short-term risk, DMAAU is less volatile compared to TPGXL. This indicates potentially lower risk in terms of short-term price fluctuations for DMAAU.Check TPGXL's competition here

Stock price comparison of stocks in the Financial Services Sector

Loading...

Frequently Asked Questions